Incidence, characteristics and outcome of ICU-acquired candidemia in India

Intensive Care Medicine

Volumn 41, Issue 2, 2015, Pages 285-295

  Chakrabarti, Arunaloke ^a,b   Sood, Prashant ^a   Rudramurthy, Shivaprakash M ^a   Chen, Sharon ^c   Kaur, Harsimran ^a   Capoor, Malini ^d   Chhina, Deepinder ^e   Rao, Ratna ^f   Eshwara, Vandana Kalwaje ^g   Xess, Immaculata ^h   Kindo, Anupama J ⁱ   Umabala, P ^j   Savio, Jayanthi ^k   Patel, Atul ^l   Ray, Ujjwayini ^m   Mohan, Sangeetha ⁿ   Iyer, Ranganathan ^o   Chander, Jagdish ^p   Arora, Anita ^q   Sardana, Raman ^r   Roy, Indranil ^s   Appalaraju, B ^t   Sharma, Ajanta ^u   Shetty, Anjali ^v   Khanna, Neelam ^w   Marak, Rungmei ^x   Biswas, Sanjay ^y   Das, Shukla ^z   Harish, B N ^aa   Joshi, Sangeeta ^ab   Mendiratta, Deepak ^ac   more..

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b Center of Advance Research in Medical Mycology   (India)

^c Pathology West ICPMR Westmead   (Australia)

^d SAFDARJUNG HOSPITAL   (India)

^e DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^f APOLLO HOSPITAL   (India)

^g KASTURBA MEDICAL COLLEGE   (India)

^h ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

ⁱ SRI RAMACHANDRA UNIVERSITY   (India)

^j NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^k ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^l Sterling Hospital   (India)

^m Apollo Gleneagles Hospital   (India)

ⁿ CHRISTIAN MEDICAL COLLEGE   (India)

^o Global Hospital   (India)

^p GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^q ESCORTS HEART INSTITUTE AND RESEARCH CENTRE   (India)

^r INDRAPRASTHA APOLLO HOSPITAL   (India)

^s CALCUTTA MEDICAL RESEARCH INSTITUTE   (India)

^t PSG INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

^u GAUHATI MEDICAL COLLEGE   (India)

^v P D HINDUJA NATIONAL HOSPITAL   (India)

^w Batra Hospital India   (India)

^x SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^y TATA MEMORIAL HOSPITAL   (India)

^z UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^aa JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^ab MANIPAL HOSPITAL   (India)

^ac MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

more..

Author keywords

Candida tropicalis; Candidemia; Intensive care unit; Mortality; Risk factor

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; CORTICOSTEROID; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POLYMYXIN; POSACONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ANTIFUNGAL RESISTANCE; APACHE; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA AURIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CATHETER REMOVAL; CENTRAL VENOUS CATHETERIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CRITICALLY ILL PATIENT; FUNGAL STRAIN; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; INDIA; INTENSIVE CARE UNIT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; OBSERVATIONAL STUDY; PARENTERAL NUTRITION; PNEUMONIA; PROSPECTIVE STUDY; PUBLIC HOSPITAL; RISK FACTOR; STEROID THERAPY; SURVIVAL; UNSPECIFIED SIDE EFFECT; ADOLESCENT; ADULT; AGED; CANDIDIASIS; CLINICAL TRIAL; CROSS INFECTION; FEMALE; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; MULTICENTER STUDY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; APACHE; CANDIDA; CANDIDEMIA; CANDIDIASIS; CROSS INFECTION; FEMALE; HUMANS; INCIDENCE; INDIA; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84924657929     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3603-2     Document Type: Article

References (33)

1. Meyer E, Geffers C, Gastmeier P et al (2013) No increase in primary nosocomial candidemia in 682 German intensive care units during 2006–2011. Euro Surveill 18(24):20505
2. Gonzalez de Molina FJ, Leon C, Ruiz-Santana S et al (2012) Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis. Crit Care 16(3):R105
3. Nolla-Salas J, Sitges-Serra A, Leon-Gil C et al (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study group of fungal infection in the ICU. Intensive Care Med 23(1):23–30
4. Charles PE, Doise JM, Quenot JP et al (2003) Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 29(12):2162–2169
5. Guery BP, Arendrup MC, Auzinger G et al (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis. Intensive Care Med 35(1):55–62
6. Lass-Florl C (2009) The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52(3):197–205
7. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20(1):133–163
8. Maubon D, Garnaud C, Calandra T et al (2014) Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med 40(9):1241–1255
9. CLSI (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard. CLSI document M27-A3, 3rd edn. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA
10. CLSI (2012) Reference method for broth dilution antifungal susceptibility testing of yeasts, fourth informational supplement. CLSI document M27-S4. Clinical and Laboratory Standards Institute, Wayne, PA
11. Playford EG, Marriott D, Nguyen Q et al (2008) Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 36(7):2034–2039
12. Leroy G, Lambiotte F, Thevenin D et al (2011) Evaluation of Candida score in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care 1(1):50
13. Kett DH, Azoulay E, Echeverria PM et al (2011) Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39(4):665–670
14. Bassetti M, Merelli M, Righi E et al (2013) Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 51(12):4167–4172
15. Chow JK, Golan Y, Ruthazer R et al (2008) Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 36(7):1993–1998
16. Leroy O, Gangneux JP, Montravers P et al (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37(5):1612–1618
17. Pappas PG, Rex JH, Lee J et al (2003) A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37(5):634–643
18. Chen S, Slavin M, Nguyen Q et al (2006) Active surveillance for candidemia, Australia. Emerg Infect Dis 12(10):1508–1516
19. Leroy O, Mira JP, Montravers P et al (2010) Comparison of albicans vs. non-albicans candidemia in French intensive care units. Crit Care 14(3):R98
20. Pfaller MA, Messer SA, Moet GJ et al (2011) Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY antimicrobial surveillance program (2008–2009). Int J Antimicrob Agents 38(1):65–69
21. White MH (1997) The contribution of fluconazole to the changing epidemiology of invasive candidal infections. Clin Infect Dis 24(6):1129–1130
22. Lortholary O, Renaudat C, Sitbon K et al (2014) Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med 40(9):1303–1312
23. Chakrabarti A, Chatterjee SS, Rao KL et al (2009) Recent experience with fungaemia: change in species distribution and azole resistance. Scand J Infect Dis 41(4):275–284
24. Mootsikapun P, Hsueh PR, Talwar D et al (2013) Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label phase III trial. BMC Infect Dis 13:219
25. Fournier P, Schwebel C, Maubon D et al (2011) Antifungal use influences Candida species distribution and susceptibility in the intensive care unit. J Antimicrob Chemother 66(12):2880–2886
26. Blot S, Janssens R, Claeys G et al (2006) Effect of fluconazole consumption on long-term trends in candidal ecology. J Antimicrob Chemother 58(2):474–477
27. Lockhart SR, Messer SA, Gherna M et al (2009) Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol 47(4):1216–1217
28. Leon C, Ostrosky-Zeichner L, Schuster M (2014) What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med 40(6):808–819
29. Blot SI, Vandewoude KH, Hoste EA et al (2002) Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113(6):480–485
30. Nucci M, Anaissie E, Betts RF et al (2010) Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 51(3):295–303
31. Gudlaugsson O, Gillespie S, Lee K et al (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37(9):1172–1177
32. Das I, Nightingale P, Patel M et al (2011) Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis 15(11):e759–e763
33. Colombo AL, Guimaraes T, Sukienik T et al (2014) Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med 40(10):1489–1498